MEZZION PHARMA CO.,LTD.

Other languages Mezzion Pharma Co.,Ltd.

Equities

A140410

KR7140410002

End-of-day quote Korea S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
37,750 ^KRW	-2.45%		+2.58%	-3.21%

18/03	Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Mezzion Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15
Mezzion Pharma Co.,Ltd. Submits Protocol for Confirmatory Pivotal Phase 3 Trial ("FUEL-2") in Fontan Subjects	21/23/21
Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11
Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12
Mezzion Pharma Co.,Ltd. Receives Clear FDA Path Forward for the Approval of Udenafil for Single Ventricle Heart Disease	31/22/31
Mezzion Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	11/22/11
Mezzion Pharma Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	23/22/23
Mezzion Pharma Announces Positive Data Presented to FDA in Type C Meeting	21/21/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer